期刊
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
卷 15, 期 4, 页码 504-535出版社
HARBORSIDE PRESS
DOI: 10.6004/jnccn.2017.0050
关键词
-
类别
This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezoli-zumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据